company
RAYSEARCH LABORATORIES AB
Industry: Medical Devices
Jurisdiction: US
FDA Warning Letter timeline
V1 scope: FDA Warning Letters only. Additional public-record sources (SEC, CPSC, federal contracts) are on the V2 roadmap and are not surfaced here today.
- fda_recall · device_recall2026-07-08RAYSEARCH LABORATORIES AB — Class II recall: RayCare 2024A SP4. Oncology Information Systems.
- fda_recall · device_recall2026-07-08RAYSEARCH LABORATORIES AB — Class II recall: RayCare 2024A SP1. Oncology Information Systems.
Frequently asked questions
- How many FDA warning letters has RAYSEARCH LABORATORIES AB received?
- Argus HQ has not recorded an FDA warning letter for RAYSEARCH LABORATORIES AB in our current dataset.
- What FDA recalls has RAYSEARCH LABORATORIES AB issued?
- Argus HQ has recorded 2 FDA recalls tied to RAYSEARCH LABORATORIES AB.
- Is RAYSEARCH LABORATORIES AB FDA compliant?
- Argus HQ is not a compliance rating service. As of this page's last update, our dataset shows 0 warning letters, 2 recalls, and 0 approval records for RAYSEARCH LABORATORIES AB. Review the linked FDA source records directly before drawing a compliance conclusion.
Informational only. FDA Warning Letters are public records (17 USC §105). Summaries are AI-assisted and may contain errors; always verify against the original FDA letter before acting. Not legal, financial, or regulatory advice.

